NO970870L - Mellomprodukter for dinukleotid- og oligonukleotid-analoger - Google Patents

Mellomprodukter for dinukleotid- og oligonukleotid-analoger

Info

Publication number
NO970870L
NO970870L NO970870A NO970870A NO970870L NO 970870 L NO970870 L NO 970870L NO 970870 A NO970870 A NO 970870A NO 970870 A NO970870 A NO 970870A NO 970870 L NO970870 L NO 970870L
Authority
NO
Norway
Prior art keywords
group
hydrogen
hydrocarbyl
halogen
oxyl
Prior art date
Application number
NO970870A
Other languages
English (en)
Other versions
NO970870D0 (no
Inventor
Anthony David Baxter
Roger John Taylor
Stephen Paul Collingwood
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO970870D0 publication Critical patent/NO970870D0/no
Publication of NO970870L publication Critical patent/NO970870L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Forbindelse med fonnel (I) eller et salt derav, der R° er hydrogen, eller sanmen med r''o betegner en Cj^-C^g hjdrokarbylidendiokslgruppe, R er hydrogen, R^^ eller en gruppe med fonæl (II), R^-^ er R^j, eller en besltyttende gruppe Q, R^i, er Cj^-Cao alkyl, C2-C20 aUtenyl, C^-Cy^ cykloalkyl, Cjj-C^j aryl, Cy-Cif, aralkyl eller en 5- eller 6-leddet hetercxykllsk gruppe festet med et karbonaton 1 den heterocykliske gruppen til det ai^ltte fosforatom, R^ er R^^ eller -OR^^ eller saranen med R^ betegner en okslgruppe -0-, forutsatt at R^ er -OR^^ når R^ er en gruppe med formel (II), R^a ^f" ^" '^l'^0 alifatisk gruppe, en C^-Cyo cykloallfatlsk gruppe, en Cjj-Cjg aronatlsk gruppe, en O^Cyf, arallfatlsk gruppe, eller en 5- eller 6-leddet heterocyklisk gruppe festet til et karbonatcni i den heterocykliske gruppe til det angitte fosforaton, R^ er r\ eller Z, R^^ ^^ hydrogen, halogen, hydroksl, R^^, -OR^^, OCOrI^, -OSOgR^^, eller trKC^-Cjj hydrokarbyl)3llyloksl. R'' er fxydrogen, haloen eller R^'', R^ er R^^ eller Z eller samoen med R^ betegner en okslgruppe -0-, R^^ ^'" hydrogen, halogen, hydroksl, R^ , -OR^^, -OCOR^^, -CSOoR^^, eller trl(Ci-Ci5 hydrokarbyl )slly loks i, eller saimen med R^ betegner en Cj^-C^g hydrokarbylldendl okslgruppe, R° er halogen, hydroksy, -OR^'', -OCOR^', -OSOgR^' eller B^, eUer sanmen med R^ betegner en Cj^-C^g hydrokarbylldendlokslgruppe, forutsatt at R^ ikke er B^ når R^ er en gruppe med fonnel (II) hvori rI* er B^, R^ er hydrogen eller r\, r\ ^f" ^°- ¦^°^^°¦ '^2^'^° ^l^^'" ^"'^'^^1-^15 hydrokarbyl)sllyl, eller sanmen med det tlUmyttede oksigenatom og R° betegner en C^-Cis hydrokarbylidendlokslgruppe, R^ er hydrogen, halogen, hydroksy, r21, -OR^l, -OCOR^'-, -OSOaR^^ eller samnen wed r1° betegner en valensbinding, r' er hydrogen, halogen eller R^^, rIO er hydrogen, halogen, hydroksl, R^-^, -OR^^, -æOR^^ eller -OSOaR^"', eller samæn raed R^ betegner en valensbinding, usubstiteurt C6 til C10 aryloksitiokarbonyloksi.
NO970870A 1994-09-03 1997-02-26 Mellomprodukter for dinukleotid- og oligonukleotid-analoger NO970870L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9417746A GB9417746D0 (en) 1994-09-03 1994-09-03 Chemical compounds
PCT/GB1995/001955 WO1996008503A1 (en) 1994-09-03 1995-08-17 Intermediates for dinucleotide and oligonucleotide analogues

Publications (2)

Publication Number Publication Date
NO970870D0 NO970870D0 (no) 1997-02-26
NO970870L true NO970870L (no) 1997-04-17

Family

ID=10760791

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970870A NO970870L (no) 1994-09-03 1997-02-26 Mellomprodukter for dinukleotid- og oligonukleotid-analoger

Country Status (10)

Country Link
US (1) US5952478A (no)
EP (1) EP0778843A1 (no)
JP (1) JPH10506621A (no)
AU (1) AU695607B2 (no)
CA (1) CA2198900A1 (no)
FI (1) FI970765A (no)
GB (1) GB9417746D0 (no)
HU (1) HUT76857A (no)
NO (1) NO970870L (no)
WO (1) WO1996008503A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US6639061B1 (en) 1999-07-07 2003-10-28 Isis Pharmaceuticals, Inc. C3′-methylene hydrogen phosphonate oligomers and related compounds
GB9604669D0 (en) 1996-03-05 1996-05-01 Ciba Geigy Ag Chemical compounds
GB9612600D0 (en) * 1996-06-13 1996-08-21 Ciba Geigy Ag Chemical compounds
US6414135B1 (en) 1999-07-07 2002-07-02 Isis Pharmaceuticals, Inc. C3′-methylene hydrogen phosphonate monomers and related compounds
US8324179B2 (en) * 2007-02-09 2012-12-04 Gilead Sciences, Inc. Nucleoside analogs for antiviral treatment
EA025341B1 (ru) 2010-09-22 2016-12-30 Алиос Биофарма, Инк. Замещенные аналоги нуклеотидов
CA2860234A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
WO2013142124A1 (en) 2012-03-21 2013-09-26 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
NZ630805A (en) 2012-03-22 2016-01-29 Alios Biopharma Inc Pharmaceutical combinations comprising a thionucleotide analog

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3307744A1 (de) * 1983-03-04 1984-09-06 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig 2'-desoxy-3'-phosphonylmethyl-nucleoside
DE4037363A1 (de) * 1990-04-09 1991-10-10 Europ Lab Molekularbiolog 2-0-alkylnukleotide sowie polymere, die solche nukleotide enthalten
US5378825A (en) * 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
GB9304618D0 (en) * 1993-03-06 1993-04-21 Ciba Geigy Ag Chemical compounds
GB9311682D0 (en) * 1993-06-05 1993-07-21 Ciba Geigy Ag Chemical compounds

Also Published As

Publication number Publication date
FI970765A0 (fi) 1997-02-24
NO970870D0 (no) 1997-02-26
HUT76857A (en) 1997-12-29
EP0778843A1 (en) 1997-06-18
WO1996008503A1 (en) 1996-03-21
AU695607B2 (en) 1998-08-20
GB9417746D0 (en) 1994-10-19
US5952478A (en) 1999-09-14
CA2198900A1 (en) 1996-03-21
FI970765A (fi) 1997-04-25
JPH10506621A (ja) 1998-06-30
AU3229695A (en) 1996-03-29

Similar Documents

Publication Publication Date Title
NO970870L (no) Mellomprodukter for dinukleotid- og oligonukleotid-analoger
IE801713L (en) N-(3-mercapto-2-alkyl-1-oxopropyl)-2,¹3-dihydro-1h-indole-2-carboxylic acids
NO306062B1 (no) Syremellomprodukter til bruk ved fremstilling av taxanderivater
EP0248420A3 (en) Benzopyran derivatives
ES8300699A1 (es) Procedimiento para la preparacion de derivados del indol.
SE7703068L (sv) Nya sulfonamido-bensoesyraderivat jemte sett for deras framstellning
FI865075A0 (fi) Nya foereningar.
ES483214A1 (es) Un procedimiento para la preparacion de compuestos derivadosde morfolina y piperidina
FI885544A0 (fi) Nya foereningar.
ES8104309A1 (es) Procedimiento para preparar enaminas
IL78625A0 (en) Furanone derivatives and their preparation
ES8104242A1 (es) Un procedimiento para la preparacion de nuevos derivados de hidantoina.
DK157540C (da) Analogifremgangsmaade til fremstilling af sekundaere 2-aminoalkyl-5-pyridinoler eller farmaceutisk acceptable syreadditionssalte deraf.
AU574130B2 (en) N-acyl amino acid derivatives
GR3025998T3 (en) Process for preparing heterocyclic derivatives
ATE109764T1 (de) Beta-lactamverbindungen und deren herstellung.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application